IRUS-ANZ has moved. From January 2022, new monthly statistics will only be added to the IRUS R5 service. This site is archived. All statistics up to December 2021 will remain available on this site.

Item Statistics

CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common beta chain of the IL-3, GM-CSF and IL-5 receptors

RepositoryUniversity of Melbourne [Minerva Access]
URLhttp://hdl.handle.net/11343/208963
Author(s)orcid:0000-0001-7430-0135; orcid:0000-0002-3101-1138; Panousis, C; Dhagat, U; Edwards, KM; Rayzman, V; Hardy, MP; Braley, H; Gauvreau, GM; Hercus, TR; Smith, S; Sehmi, R; McMillan, L; Dottore, M; McClure, BJ; Fabri, LJ; Vairo, G; Lopez, AF; Parker, MW; Na
Item typeArticle
JournalmAbs, Print_ISSN:1942-0870, Online_ISSN:1942-0862
DOIhttps://doi.org/10.1080/19420862.2015.1119352

Sorry - we've not seen any usage for this item in the last six weeks...

Jisc logo Cranfield logo CAVAL logo